BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 164509)

  • 1. Mastocytoma cell migration in vitro: inhibition by MIF-containing supernatants.
    Cohen MC; Zeschke R; Bigazzi PE; Yoshida T; Cohen S
    J Immunol; 1975 May; 114(5):1641-3. PubMed ID: 164509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of leucocyte inhibitory factor (LIF) and macrophage inhibitory factor (MIF) by PHA-stimulated lymphocytes.
    Ruthlomnitzer ; Rabson AR; Koornhof HJ
    Clin Exp Immunol; 1975 Dec; 22(3):522-7. PubMed ID: 773578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphokines in sensitized rats. I. Migration inhibitory factor(s) from specifically stimulated thymocytes in vitro.
    Bakker WW; Engelhart JJ; Mulder I; Hoedemaeker PJ
    Int Arch Allergy Appl Immunol; 1975; 49(4):491-503. PubMed ID: 1099009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of lymphokine-like factors (cytokines) by simian virus 40-infected and simian virus 40-transformed cells.
    Bigazzi PE; Yoshida T; Ward PA; Cohen S
    Am J Pathol; 1975 Jul; 80(1):69-78. PubMed ID: 168779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of a serine-protease with macrophage migration-inhibitory factor activity by virus-transformed cells and human tumor cell lines.
    Poste G
    Cancer Res; 1975 Sep; 35(9):2558-66. PubMed ID: 167963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune interferon. II. Different cellular site for the production of murine macrophage migration inhibitory factor and interferon.
    Neumann C; Sorg C
    Eur J Immunol; 1978 Aug; 8(8):582-9. PubMed ID: 359337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inability to block the activity of guinea pig migration inhibitory factor with di-isopropyl phosphorofluoridate.
    David JR; Becker EL
    Eur J Immunol; 1974 Apr; 4(4):287-9. PubMed ID: 4604594
    [No Abstract]   [Full Text] [Related]  

  • 8. Characterization of macrophage migration inhibitory factor activity produced in vivo by a cell-mediated immune reaction in the guinea pig.
    Postlethywaite AE; Townes AS; Kang AH
    J Immunol; 1976 Nov; 117(5 Pt 1):1716-20. PubMed ID: 794416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell-mediated immune reactions in vitro to cell walls and peptidoglycan from Staphylococcus aureus.
    Targowski SP; Berman DT
    Z Immunitatsforsch Exp Klin Immunol; 1975 Jul; 149(2-4):295-301. PubMed ID: 126563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of migration of tumor cells in vitro by lymphokine-containing supernatants.
    Cohen MC; Goss A; Yoshida T; Cohen S
    J Immunol; 1978 Sep; 121(3):840-3. PubMed ID: 99477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of Lotus-tetragonolobus Lectin (LTL) and an MIF-like factor with guinea-pig macrophages. I. Effects on macrophage migration inhibition and receptor-binding studies.
    Fahlbusch B; Wollweber L; Drössler K; Scherbaum I; Zschiesche W
    Immunobiology; 1982 Aug; 162(3):251-64. PubMed ID: 6752005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphokines. VI. Factors in human and other heterologous sera inhibiting the migration of guinea pig macrophages.
    Baer R; Vogt K; Lazary S; Geczy C; de Weck AL
    Z Immunitatsforsch Immunobiol; 1978 Dec; 155(2):130-43. PubMed ID: 746681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage requirement for production of guinea pig migration inhibitory factor (MIF) in vitro.
    Nelson RD; Leu RW
    J Immunol; 1975 Feb; 114(2 Pt 1):606-9. PubMed ID: 47355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Refractoriness to migration inhibitory factor of macrophages of LPS nonresponder mouse strains.
    Tagliabue A; McCoy JL; Herberman RB
    J Immunol; 1978 Oct; 121(4):1223-6. PubMed ID: 359704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guinea pig lymphocyte-derived macrophage aggregation factor: its separation from macrophage migration inhibitory factor.
    Postlethwaite AE; Kang AH
    J Immunol; 1976 Nov; 117(5 Pt 1):1651-5. PubMed ID: 794415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The production of anti-guinea pig lymphokine antibody.
    Yoshida T; Bigazzi PE; Cohen S
    J Immunol; 1975 Feb; 114(2 Pt 1):688-91. PubMed ID: 1091701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse bone marrow-cultured macrophage as indicator cells for mouse and human migration inhibitory factor (MIF).
    Lohmann-Matthes ML; Domzig W; Meerpohl HG
    Eur J Immunol; 1977 Aug; 7(8):585-8. PubMed ID: 332509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Species-restricted effects of human and mouse lymphokines on macrophages.
    Tagliabue A; Mantovani A; Boraschi D; Herberman RB
    Eur J Immunol; 1980 Jul; 10(7):542-6. PubMed ID: 6157542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen-enhanced glucosamine incorporation by peritoneal macrophages in cell-mediated hypersensitivity. I. Studies on biology and mechanism.
    Hammond ME; Selvaggio SS; Dvorak HF
    J Immunol; 1975 Oct; 115(4):914-21. PubMed ID: 1100724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial purification and physicochemical properties of human T cell migration inhibitory factor (TIF).
    Kowalczyk D; Staykowa M; Litwora E; Pryjma J; Zembala M
    J Clin Lab Immunol; 1984 Oct; 15(2):105-10. PubMed ID: 6394762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.